


Altus Drug Development Revenue
Pharmaceutical Manufacturing • Laval, Quebec, Canada • 1-10 Employees
Altus Drug Development revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at Altus Drug Development
Beth Hickey
International Director of Marketing and Business Development
Company overview
| Headquarters | 500 Cartier Blvd W, Laval , Québec H7V 5B7, CA |
| Website | |
| NAICS | 3254 |
| Keywords | Product Design, Patents, Formulation, Drug Development, Hybrid, Analytical Development, 505(B)(2), Microparticles, Reformulation, Co-Development, Extended Release, ODT, Controlled Release, Drug Product, Modified Release, Oral Solid Dose, Value Added Medicines, Branded Generic, 10(3), Complex Generic |
| Founded | 2012 |
| Employees | 1-10 |
About Altus Drug Development
Leveraging our 20 years plus history of 505(b)(2), Hybrid and Complex Generic approvals, Altus Drug Development designs, develops and delivers new Value-Added Medicines to pharma companies seeking cost-effective ways to compete in today’s challenging market. Simple reformulations fill the gap between high risk NCE’s and low-return generics. Altus’ Value Added Medicines go further, providing patent-protected label differentiated benefits to improve the lives of patients, offer new options to physicians and enhance your bottom line. Contact us today to learn how Altus can unlock the value in mature pipelines and expand existing portfolios with differentiated new products.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Altus Drug Development has never raised funding before.
Frequently asked questions
4.8
40,000 users



